Cargando…
Role of the Pharmacist in Managing Treatment-Resistant Depression: A Focus on Ketamine
The impact of depression is well described in the literature, and it is most prominent in patients who have trialed multiple treatments. Treatment-resistant depression (TRD) is particularly debilitating, and it is associated with significant morbidity and mortality. Despite this, there seems to be t...
Autores principales: | Liu, Linda Xing Yu, Golts, Marina, Fernandes, Virginia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8293424/ https://www.ncbi.nlm.nih.gov/pubmed/34202267 http://dx.doi.org/10.3390/pharmacy9030118 |
Ejemplares similares
-
Efficacy of Ketamine with and without Lamotrigine in Treatment-Resistant Depression: A Preliminary Report
por: Joseph, Boney, et al.
Publicado: (2023) -
Ketamine enhances structural plasticity in human dopaminergic neurons: possible relevance for treatment-resistant depression
por: Collo, Ginetta, et al.
Publicado: (2018) -
The role of dissociation in ketamine’s antidepressant effects
por: Ballard, Elizabeth D., et al.
Publicado: (2020) -
Therapeutic Modalities for Treatment Resistant Depression: Focus on Vagal Nerve Stimulation and Ketamine
por: Shah, Aparna, et al.
Publicado: (2014) -
The role of immunomodulators in treatment-resistant depression: case studies
por: Beckett, Charles W., et al.
Publicado: (2022)